InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（1 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
1
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the full record of transactions filed by Epstein Robert S, Director. Officer active across 3 companies, notably Veracyte, INC.. In total, 18 filings have been recorded. Breakdown: 0 buy · 1 sell. Total volume traded: €379k. History available since 25 May 2021. The latest transaction was disclosed on 20 May 2026 (Cession). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Epstein Robert S
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报18 总计
5,272 股Common StockSEC:0001252004-26-000004:0
10,000 股@ US$44.01290.011% mcap48.3% 占其流量Common StockSEC:0001252004-26-000002:0
10,000 股@ US$7.940.0022% mcap50.0% 占其流量Common StockSEC:0001252004-25-000005:0
9,321 股0Common StockSEC:0001384101-25-000096:0
3,780 股0Common StockSEC:0001127602-25-015513:0
20,000 股@ US$8.0419.9% 占其流量Common StockSEC:0001384101-25-000004:0
15,000 股@ US$8.0414.4% 占其流量Common StockSEC:0001384101-24-000165:0
11,473 股0Common StockSEC:0001384101-24-000101:0
612 股@ US$115.0115.7% 占其流量Common StockSEC:0001127602-24-015931:0
9,674 股0Common StockSEC:0001384101-23-000121:0
1,532 股0Common StockSEC:0001127602-23-017237:0
492 股@ US$212.6523.6% 占其流量Common StockSEC:0001127602-23-016874:0
14,731 股0Common StockSEC:0001384101-22-000098:0
8,650 股0Common StockSEC:0001209191-22-036345:0
1,232 股0Common StockSEC:0001127602-22-015920:0
8,720 股0Common StockSEC:0001384101-21-000114:0
2,681 股0Common StockSEC:0000899243-21-022085:0
385 股@ US$397.0943.5% 占其流量Common StockSEC:0001127602-21-018202:0
18 条申报中的 18 条
About Epstein Robert S
Robert S. Epstein is a Board Member at Veracyte, Inc., Illumina, Inc., and Fate Therapeutics Inc. He brings expertise in corporate governance and strategy. His role involves overseeing operations and contributing to strategic decision-making within these companies. Through his experience, he plays a key role in shaping governance policies and practices, ensuring compliance and organizational effectiveness.
